Cite
HARVARD Citation
Beeske, S. et al. (2018). Alirocumab decreases plasma Lp(a) levels without enhancing Lp(a) liver uptake in vivo. Atherosclerosis. pp. e17-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Beeske, S. et al. (2018). Alirocumab decreases plasma Lp(a) levels without enhancing Lp(a) liver uptake in vivo. Atherosclerosis. pp. e17-. [Online].